Department of Public Health, Faculty of Medicine, Gadjah Mada University, Jogjakarta, Indonesia.
Am J Trop Med Hyg. 2010 Jun;82(6):1131-9. doi: 10.4269/ajtmh.2010.09-0447.
We aimed to evaluate the incremental cost-effectiveness of engaging private practitioners (PPs) to refer tuberculosis (TB) suspects to public health centers in Jogjakarta, Indonesia. Effectiveness was assessed for TB suspects notified between May 2004 and April 2005. Private practitioners referred 1,064 TB suspects, of which 57.5% failed to reach a health center. The smear-positive rate among patients reaching a health center was 61.8%. Two hundred eighty (280) out of a total of 1,306 (21.4%) new smear-positive cases were enrolled through the PPs strategy. The incremental cost-effectiveness ratio per smear-positive case successfully treated for the PPs strategy was US$351.66 (95% CI 322.84-601.33). On the basis of an acceptability curve using the National TB control program's willingness-to-pay threshold (US$448.61), we estimate the probability that the PPs strategy is cost-effective at 66.8%. The strategy of engaging PPs was incrementally cost-effective, although under specific conditions, most importantly a well-functioning public directly observed treatment, short-course (DOTS) program.
我们旨在评估在印度尼西亚日惹市聘请私人医生(PPs)将结核病(TB)疑似病例转介到公共卫生中心的增量成本效益。评估了 2004 年 5 月至 2005 年 4 月间通报的 TB 疑似病例的有效性。私人医生转诊了 1064 例 TB 疑似病例,其中 57.5%未到达卫生中心。到达卫生中心的患者中涂片阳性率为 61.8%。通过私人医生策略共登记了总共 1306 例新的涂片阳性病例中的 280 例(21.4%)。私人医生策略每成功治疗一例涂片阳性病例的增量成本效益比为 351.66 美元(95%CI 322.84-601.33)。基于使用国家结核病控制规划支付意愿阈值(448.61 美元)的可接受性曲线,我们估计私人医生策略具有成本效益的概率为 66.8%。尽管在特定条件下,特别是在运行良好的公共直接观察治疗短程化疗(DOTS)方案下,聘请私人医生的策略具有增量成本效益。